, Tracking Stock Market Picks
Enter Symbol:
Endologix Inc (ELGX) [hlAlert]

down 15.45 %

Endologix Inc (ELGX) rated Buy with price target $15 by Stifel

Posted on: Wednesday,  Oct 1, 2014  8:25 AM ET by Stifel

Stifel rated Buy Endologix Inc (NASDAQ: ELGX) on 10/01/2014. Previously Stifel rated Buy Endologix Inc (NASDAQ: ELGX) on 07/12/2013.,
when the stock price was $15.33. Since then, Endologix Inc has lost 15.46% as of 01/14/2016's recent price of $12.96.
If you would have followed the previous Stifel's recommendation on ELGX, you would have lost 15.45% of your investment in 916 days.

Endologix, Inc., incorporated in March 1992, develops, manufactures, markets and sells treatments for aortic disorders. The Company?s product, the Powerlink System is a minimally invasive device for the treatment of abdominal aortic aneurysm (AAA). AAA is a weakening of the wall of the aorta, an artery of the body. Once AAA develops, it continues to enlarge and if left untreated becomes susceptible to rupture. The Powerlink System is a catheter and endoluminal stent graft (ELG) system. The device consists of a self-expanding cobalt chromium alloy stent cage covered by expanded polytetrafluoroethylene (ePTFE), a surgical graft material. Sale of its Powerlink System in the United States, Europe, Japan and Latin America are the primary sources of the Company?s revenues.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/1/2014 8:25 AM Buy
10.57 15.00
as of 10/17/2014
1 Week up  4.04 %
1 Month down  -19.43 %
3 Months down  -19.94 %
1 YTD down  -35.09 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/12/2013 9:25 AM Buy
15.33 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy